[11, 12] Furthermore, approximately 30% of HCC patients exhibit dephosphorylation of tumor suppressors MST1/2 and inactivation of the kinase cascade of the Hippo pathway, followed by high YAP/TAZ activity, indicating the important role of the Hippo pathway and its target genes in HCC. The gene discussed is YAP1; the disease is hepatocellular carcinoma.